XpressEngine Multiple HTML Injection Vulnerabilities
BID:49067
Info
XpressEngine Multiple HTML Injection Vulnerabilities
| Bugtraq ID: | 49067 |
| Class: | Input Validation Error |
| CVE: | |
| Remote: | Yes |
| Local: | No |
| Published: | Aug 08 2011 12:00AM |
| Updated: | Aug 08 2011 12:00AM |
| Credit: | v0nSch3lling |
| Vulnerable: |
XpressEngine XpressEngine 1.4.5.7 |
| Not Vulnerable: | |
Discussion
XpressEngine Multiple HTML Injection Vulnerabilities
XpressEngine is prone to multiple HTML-injection vulnerabilities because it fails to properly sanitize user-supplied input before using it in dynamically generated content.
Successful exploits will allow attacker-supplied HTML and script code to run in the context of the affected browser, potentially allowing the attacker to steal cookie-based authentication credentials or to control how the site is rendered to the user. Other attacks are also possible.
XpressEngine 1.4.5.7 is vulnerable; other versions may also be affected.
XpressEngine is prone to multiple HTML-injection vulnerabilities because it fails to properly sanitize user-supplied input before using it in dynamically generated content.
Successful exploits will allow attacker-supplied HTML and script code to run in the context of the affected browser, potentially allowing the attacker to steal cookie-based authentication credentials or to control how the site is rendered to the user. Other attacks are also possible.
XpressEngine 1.4.5.7 is vulnerable; other versions may also be affected.
Exploit / POC
XpressEngine Multiple HTML Injection Vulnerabilities
Attackers can use a browser to exploit these issues.
Attackers can use a browser to exploit these issues.
Solution / Fix
XpressEngine Multiple HTML Injection Vulnerabilities
Solution:
Currently, we are not aware of any vendor-supplied patches. If you feel we are in error or if you are aware of more recent information, please mail us at: [email protected].
Solution:
Currently, we are not aware of any vendor-supplied patches. If you feel we are in error or if you are aware of more recent information, please mail us at: [email protected].